Sattva Sukun Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Intimation of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sattva Sukun Lifecare Ltd has informed BSE that its Board of Directors will meet on Saturday, 14th February 2026 at its registered office in Kandivali West, Mumbai. The main item on the agenda is to consider and approve the Un-audited Financial Results (both Standalone and Consolidated) for the quarter ended 31st December 2025 (Q3 FY26). The Board will also approve the Limited Review Report on these results. Additionally, the Board will review and discuss the use of proceeds from the company's earlier Rights Issue and submit the Statement of Deviation or Variation, as required under SEBI regulations. The trading window for designated persons has already been closed from 1st January 2026 and will reopen 48 hours after the board meeting concludes.
This is a routine pre-results announcement. Shareholders should watch for the Q3 FY26 earnings on/after 14th February, which could drive short-term stock movement. The review of Rights Issue proceeds usage is also worth noting as it indicates how the company has deployed recently raised capital.